28 C
Vientiane
Saturday, October 25, 2025
spot_img
Home Blog Page 696

This Summer’s Next Trend? Stationery, Says Yiwugo

YIWU, China, Aug. 17, 2025 /PRNewswire/ — Yiwugo.com, the official website of the Yiwu Commodity Market, is the largest commodity wholesale market in the world. Big data from Yiwugo shows that, as of August 12, 2025, demand in the “office and study supplies” sector had been on a steady rise, climbing to 14th place among all categories. Traditionally a stable segment of the consumer goods market, stationery has seen a notable surge in the past 30 days, driven by the approaching back-to-school season in both China and overseas. Many Yiwugo merchants report a buying wave for office essentials and cartoon-themed stationery.

Products on www.yiwugo.com.
Products on www.yiwugo.com.

Jiangsu Dehuang Stationery Co., Ltd., with nearly 30 years of experience, boasts industry-leading design, R&D, and manufacturing capabilities. Over the years, it has established itself as a trusted supplier to both domestic and international brands. According to owner Wang Xiaohua, the company collaborates with renowned names such as Germany’s Staedtler, Faber-Castell, and Pelikan, along with France’s Maped and several leading Chinese brands. Its product line includes correction tools, sticky notes, and art crayons.

Since early summer, demand from European customers for art-related products has soared, with average monthly purchases nearing RMB 1 million. The French market, in particular, has experienced a notable upswing, fueled by a wave of new customers introduced through Yiwugo. Major general merchandise chains in Japan, Europe, and the U.S. have expressed strong satisfaction with Dehuang’s sticky notes, citing their exceptional paper durability, absence of fluorescent agent reactions, and outstanding adhesive stability—qualities that have translated into substantial annual orders.

Wang noted that Dehuang’s commitment to quality begins with the careful selection of premium raw materials and extends to the acquisition of both domestic and international certifications. Each year, the company undergoes rigorous brand-partner audits on plant design, technology, and supply capabilities. For instance, the production of correction fluid requires not only eco-friendly materials but also exceptional sealing performance. Factoring in production and transportation cycles, manufacturing a single bottle of Dehuang correction fluid costs about 1.5 times more than typical market alternatives—yet its shelf life is five to six times longer. This is a key reason for the company’s consistently high customer retention rate.

Unlike Dehuang, which has spent three decades building its reputation on quality, Yuanchang Stationery has distinguished itself through its distinctive design. According to proprietor Wu Chenjie, many customers have been sourcing office supplies via Yiwugo recently, with cartoon-themed staplers emerging as bestsellers. Models shaped like pandas, airplanes, and propellers have seen particularly strong demand.

One European client, who initially ordered only a few hundred units of each model, quickly multiplied their orders severalfold after successful trial runs—yet demand still outpaced supply. Today, whenever Yuanchang introduces a new product, this client immediately places large orders; just this month, they purchased another shipment of cartoon staplers.

As Wu pointed out, since 2023 Yuanchang has partnered with multiple design agencies to blend charm with functionality. The first major success from these collaborations—the panda stapler series—has become an overseas bestseller, now shipping more than 50,000 units each month.

In recent months, Disney-themed stationery sets have been especially popular in Southeast Asia. After securing Disney licensing, Yuanchang has curated stationery collections tailored to different markets, with monthly orders reaching around 500,000 units.

Currently, Yuanchang is busy fulfilling orders from a German retail chain. Through Yiwugo, the company has connected with a growing network of high-quality customers. Wu explained that their R&D team draws on both domestic and international feedback collected via the platform to refine their products, enhancing not only quality but also their playful appeal.

Thanks to Yiwugo’s outreach and promotion, an increasing number of premium Chinese brands—such as Dehuang—are gaining wider recognition in global markets, enabling outstanding domestic products to shine both at home and abroad.

GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation

Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation

PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ — GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 2025, underscoring its ability to deliver profitable growth at scale through strategic globalization, differentiated technology, and relentless innovation.

Fueled by robust demand across all business segments and expansion into key international markets, GenScript achieved consolidated revenue of approximately US$518.8 million for H1 2025, reflecting an exceptional 81.9% year-over-year increase. Gross profit rose 140.1% to US$320.6 million, while adjusted net profit from continuing operations surged 509.6% to US$178 million, demonstrating not only rapid growth but superior operational leverage and margin resilience.

H1 2025 Highlights and Financial Performance

  • Revenue: US$518.8 million (+81.9%); reflecting broad-based growth across all business segments and geographies.
  • Gross Profit: US$320.6 million (+140.1%); driven by enhanced capacity utilization and premium product mix.
  • Adjusted Net Profit from Continuing Operations: US$178.0 million (+509.6%); underscoring highly scalable profitability and improved operational leverage.
  • Global Presence: Meaningful growth across all regions, driven by elevated contribution from international markets
  • Sustainability Leadership: Industry-leading ESG ratings reinforcing long-term stakeholder value

“Our first-half results powerfully affirm the strength of GenScript’s innovation-led, commercially driven global strategy,” said Sherry Shao, Rotating CEO of GenScript Biotech. “We remain committed to deepening R&D investment, expanding production capacity worldwide, and accelerating market penetration to deliver sustainable growth and superior value to our customers and shareholders.”

Strategic Growth Drivers and Segment Highlights:

Innovation and Gene-to-Protein Platform Excellence

The Life Science Services and Products segment generated US$247.6 million in revenue (+11.3% YoY), powered by breakthrough increases in gene synthesis throughput. The protein business demonstrated a remarkable 52% uplift, capitalizing on surging demand, especially from AI-driven drug discovery innovators. This segment’s growth is bolstered by expanding reagent and consumable offerings and investments in automated “lights-out” manufacturing, enabling both scale and profitability.

CDMO Business Rebounds with a return to revenue growth after the industry headwind

GenScript’s biologics development CDMO services, operated under ProBio, reported US$246.9 M in revenue, an extraordinary 511.1% increase year-over-year. Adjusted gross margin expanded dramatically to 73.6%, reflecting improved capacity utilization and operational efficiencies. Excluding a one-time upfront payment tied to collaboration with LaNova, the segment sustained strong double-digit growth. ProBio has out-licensed 16 assets—4 in clinical development—and impending milestones such as the potential CD3 VHH out-licensing by late 2025 or early 2026, offer robust visibility into future revenue streams and underline long-term growth potential.

Industrial synthetic biology products’ Market Leadership and Product Innovation

Bestzyme, Industrial synthetic biology products unit, grew its revenue by 8.4%, driven by market share gains for its innovative enzyme portfolio and continued trust from key accounts.

With 61 patents granted and 61 new applications filed, Bestzyme is leading industry innovation. Its innovative synthetic biologic product, sweet protein, has earned FDA GRAS status, and the commercial manufacturing facility is expected to commence operations in mid-2026 .

Strengthening Global Reach and Market Position for the Life Science Services and Products

GenScript’s global production and R&D footprint—with major facilities in the U.S., Europe, and Asia—supports over 60% automation penetration, enabling resilient supply chains and rapid responsiveness to customers’ evolving needs. The company’s August 8 global brand relaunch, paired with its industry-leading Net Promoter Score, strengthens customer loyalty and commercial momentum, driving win rates, pricing power, and adoption of integrated, higher-margin solutions.

Unwavering Commitment to ESG, Driving Sustainable Competitive Advantage

The Group continues to lead in sustainability, with its ESG framework aligned to global best practices. The group has earned top-tier recognition, including an MSCI AA rating, EcoVadis Silver Medal, Sustainalytics “Low Risk” designation, an improved S&P Global Corporate Sustainability Assessment score of 60, and inclusion in the FTSE4Good Index Series. Its science-based carbon reduction targets are validated by the SBTi, supported by commitments through membership in the United Nations Global Compact and the Pharmaceutical Supply Chain Initiative.

These actions underscore GenScript’s commitment to responsible growth and enhance its appeal to investors who prioritize ESG as a key driver of sustainable, long-term value.

Outlook

GenScript anticipates continued growth backed by scaling automation, global brand strength, and an expanding pipeline of innovative solutions. The company is well positioned to sustain its biotech leadership, delivering differentiated solutions and creating elevated shareholder value in an evolving global healthcare and biotech landscape.

About GenScript Biotech Corporation

Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in healthcare and consumer goods by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,700 employees and has served more than 200,000 customers across 100 countries.

Learn more here: https://www.genscript.com

Europe to Mull Over Plan for Peace in Ukraine After Trump-Putin Summit

Europe to Mull Over Plan for Peace in Ukraine After Trump-Putin Summit
US President Donald Trump and Russian President Vladimir Putin meet during a US-Russia summit on Ukraine at Joint Base Elmendorf-Richardson in Anchorage, Alaska, on August 15, 2025. (Photo by ANDREW CABALLERO-REYNOLDS / AFP)

By Shaun TANDON/AFP – Leaders of France, Germany, and Britain will host a video call on Sunday for their so-called “coalition of the willing” to discuss steps towards ending the war in Ukraine, after Donald Trump dropped his push for a ceasefire after his Alaska summit with Russian leader Vladimir Putin.

XPPen Celebrates 20th Anniversary with “Back to Future, Create Now!”

XPPen & PUBG MOBILE Ultimate Set Design Contest: Leading a New Wave of Creativity

LOS ANGELES, Aug. 16, 2025 /PRNewswire/ — XPPen, the world’s leading digital art innovation brand, marked its dazzling 20th anniversary today. Under the theme “Back to Future, Create Now!”, XPPen partners with PUBG MOBILE to launch the Ultimate Set Design Contest, bridging digital art with gaming communities worldwide, featuring a prize pool of $120,000. The initiative also includes visionary conversations on the future of digital art with leading artists and offers an exclusive anniversary sale. For two decades, XPPen has remained committed to empowering creators worldwide through innovative technology, and this milestone celebration serves as a tribute to the unwavering support of our global creative community.


“With a vision to bridge technology and human art, XPPen continues to spark creativity and connect artists worldwide,” said Amy Yuan, Brand Director at XPPen. “This year, themed ‘Back to Future, Create Now’, we encourage users to pursue their dreams and envision the future. While technologies continue to reshape imagination and creativity, the essence of art remains a unique reflection of how individuals observe and contemplate the world. Viewing present through the future, grounded in warmth and humanity, we’re moving forward with greater conviction. We are honored to join hands with PUBG MOBILE, a globally renowned mobile game, for the Ultimate Set Design Contest. Through this collaboration, we not only provide a global stage for creators to showcase their talent but also strengthen XPPen’s connection with the new generation, enabling gaming enthusiasts to experience the joy of creation.”

XPPen x PUBG MOBILE Ultimate Set Design Contest: Leading a New Wave of Creativity

XPPen partners with the renowned mobile game PUBG MOBILE to launch the Ultimate Set Design Contest, inviting creators worldwide to explore creative frontiers. Ptopia Design Project (PDP) is the first global community-sourced co-creation program for PUBG MOBILE, inspiring players to develop outfits, weapons, accessories and more. This partnership is derived from a shared passion for innovation, open spirit, and creativity, as well as a vision to foster co-creation, cultural exchange, and a global creative platform.


The contest runs from August 16 to October 16, 2025, featuring popular themes and an exclusive new theme co-created by XPPen and PUBG MOBILE: “Future Era,” encouraging participants to envision the future. Prizes include a $120,000 prize pool, flagship XPPen drawing displays and PUBG MOBILE props, with winning designs potentially featured in-game. Join the contest at https://community.xp-pen.com/events/co-create-with-pubgm-pdp  

A panel of esteemed artists will judge the entries, including Clinton Jones (Pwnisher), acclaimed director and 3D/VFX artist known for curating global 3D challenges; Esteban Diácono, motion designer who has collaborated with leading brands; Ryota-H, renowned Japanese animator and manga artist; along artists Shan Jiang and Giusy Amoroso. “This is a fantastic opportunity. I look forward to seeing participants give their best,” says lead judge Clinton Jones.

Reshaping the Future of Creative Tools

Since 2005, XPPen has been driven by innovation, enabling technology accessible to all. Recent breakthroughs include the Magic Drawing Pad and Magic Note Pad, extending the reach of digital drawing and writing technology to a broader audience while opening new frontiers in mobile creation and business applications. XPPen’s product lineup ranges from professional-grade to portable solutions, addressing diverse user needs with versatile creative experiences across scenarios. Looking ahead, XPPen will introduce a new-generation stylus powered by advanced chip technology, offering superior sensitivity, stability, and portability to elevate creation experience. The upcoming Artist Ultra series will strike the perfect balance between professional performance and portable design, redefining the creative tools.

Exclusive Anniversary Offers, Up to 50% Off

To mark XPPen’s 20th anniversary, the official store offers up to 50% off the popular lineup, giving creators a chance to experience the cutting-edge technology at exceptional value. Follow our social media and community for more celebration activities and opportunities to win XPPen products and exclusive anniversary gift sets.

Join XPPen’s 20th anniversary celebration as we continue to pioneer innovation and inspire creators to reach new heights. Experience the future of digital creativity and be part of our journey. For more information, please visit https://www.xp-pen.com/20th-anniversary-celebration.html 

Mohamed bin Zayed University of Artificial Intelligence begins new academic year with largest-ever cohort of 400+ students

ABU DHABI,UAE, Aug. 16, 2025 /PRNewswire/ — Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has welcomed its largest cohort for its Fall 2025 intake, enrolling 403 new students. This includes its inaugural undergraduate class, new graduate cohorts in existing programmes in Computer Science, Computer Vision, Machine Learning, Natural Language Processing, and Robotics, and the first intakes into the Master of Science in Statistics & Data Science and Master in Applied Artificial Intelligence.

Students arrive at MBZUAI in Abu Dhabi as the university begins the 2025 academic year with its largest-ever class of 400+ students
Students arrive at MBZUAI in Abu Dhabi as the university begins the 2025 academic year with its largest-ever class of 400+ students

This semester received more than 8,000 applications across the university’s Bachelor and graduate programmes, yielding an acceptance rate of 5 per cent, and reinforcing the university’s prestigious position and ability to attract the best talent in the UAE and from around the world.

Timothy Baldwin, MBZUAI Provost and Professor of Natural Language Processing, said: “This year, MBZUAI welcomes our largest cohort of graduate students alongside our inaugural undergraduate class. Artificial intelligence is transforming the world at a pace that vastly outstrips traditional education models. To realise its full global potential, MBZUAI invests heavily in reviewing and updating our programmes to reflect modern AI research methodology and workflows, based on our bleeding-edge AI research credentials and grounded in societal and industrial needs. As a young institution, MBZUAI has already earned a place among the world’s top 10 AI universities based on our research credentials. With the introduction of our undergraduate and Master’s in Applied AI programmes, we continue to build world-leading programmes aligned with the UAE’s National Strategy for AI 2031 and supporting Abu Dhabi’s rapidly growing AI ecosystem.”

The newly launched Bachelor of Science in Artificial Intelligence programme offers two streams, AI for Business and AI for Engineering, combining technical rigor with leadership, hands-on entrepreneurship, and in-situ industry experience. The first class consists of 115 undergraduate students from more than 25 countries, over 25 per cent of which are UAE Nationals.

Professor Baldwin said: “The jobs of tomorrow are being shaped by AI today and we must ensure that future generations are equipped with the tools and skills to navigate that shift. Our extraordinarily talented students don’t just learn about AI, but learn with it, through it, and for it. This is an extraordinary value proposition across all our programmes, but especially for our undergraduate students, who will be studying towards a bachelor’s degree in AI that I believe sets a new global benchmark in terms of technical depth, real-world relevance, and the high-end AI job-readiness of the students.”

The key highlights for the Fall 2025 intake includes MBZUAI’s total student body totaling more than 700, representing over 47 nationalities.

Nationalities represented in the undergraduate programmes are Bulgaria, China, Egypt, Georgia, Greece, India, Indonesia, Kazakhstan, the UAE and the UK. Postgraduate programmes bring together students from Canada, China, Egypt, France, India, Italy, Kazakhstan, Serbia, UAE, UK, USA and Vietnam.

MBZUAI continues to attract exceptional students, with 151 of the incoming graduate students (27.5 per cent) holding degrees from the world’s top 100 computer science universities (CSRankings), including Cornell University, Tsinghua University, the University of Edinburgh, and the University of California, San Diego.

In welcoming the new students, MBZUAI has begun its immersive Orientation Week, introducing new students to the university’s culture of academic excellence, AI-driven innovation, and community engagement. The programme combines academic sessions, mentorship activities, and cultural programming celebrating UAE heritage and life in Abu Dhabi. Highlights include the Orientation Mini Fair, where internal and external partners showcase resources for academic success, career development, and student life.

Orientation Week is designed to foster a strong sense of belonging and connection, laying the foundation for academic success and life-changing university experiences.

For more information, visit www.mbzuai.ac.ae 

Media Contact:
Noorul Tharola
Noorul.Tharola@edelman.com
+971567436637

All InX Launches Next-Gen RWA Platform: Where Wall Street Meets Web3

HANOI, Vietnam, Aug. 16, 2025 /PRNewswire/ — With BlackRock’s BUIDL fund surpassing $1.2 billion in assets and the EU’s MiCA framework officially in force, institutional appetite for compliant real-world asset (RWA) solutions has reached a new high. In response, All InX today announced the launch of its full-stack RWA platform designed to connect traditional asset classes with the efficiency and programmability of blockchain.

A Compliance-First RWA Infrastructure

Unlike many experimental Web3 ventures, All InX debuts with a firm regulatory foundation. The platform is registered as a Money Services Business (MSB) with the U.S. FinCEN and has passed security reviews to be listed on both the Apple App Store and Google Play. Its approach centers on tangible value, working with partners in sectors such as biotech and commercial real estate to bring verified, income-generating assets on-chain.

Yield Optimization Meets Institutional-Grade Infrastructure

At its core, All InX combines RWA issuance, derivatives, and smart asset management in a modular architecture. Its staking mechanism, Nexus, supports auto-compounding rewards linked directly to asset flows. Early users have reported returns significantly above benchmark treasury yields, enabled by diversified exposure to assets ranging from medical agriculture to intellectual property and stabilized real estate portfolios.

Cross-Border Utility

With offices in five global financial centers—New York, London, Hong Kong, Kuala Lumpur, and Seoul—All InX tackles longstanding frictions in cross-border finance. Its forthcoming crypto-linked debit card, launching later this year, will allow seamless conversion from tokenized assets to fiat currencies—meeting the needs of both institutional clients and individual users.

Laying the Rails for the Tokenized Economy

Rather than offering another single-purpose application, All InX positions itself as an infrastructure layer for the next generation of capital markets. By integrating regulatory compliance, liquidity mechanisms, and direct access to real-world asset classes, the platform provides a viable framework for how corporates might eventually tokenize balance sheets, unlock new sources of capital, and operate across chains and jurisdictions. For more details, please visit www.allinpro.com.

About All InX

As the world’s first fully on-chain RWA asset management and trading platform, All InX is pioneering the next era of digital finance — a unified platform that integrates Real-World Asset (RWA) tokenization, AI-powered strategies, and Web3 infrastructure to unlock borderless, smart asset growth for everyone.

Redefining Hospitality and Commercial Artwork Standards: A Full-Spectrum Solution for Space Art’s Four Critical Pain Points

BEIJING, Aug. 16, 2025 /PRNewswire/ — Empowering Art Narratives for Luxury Hospitality & Premium Commercial Interiors

In the high-stakes world of custom artwork for luxury hotels and premium commercial spaces, owners and designers face fractured processes: disjointed art integration, budget overruns, and diluted cultural storytelling. For over 20 years, ZhengyinArt has pioneered end-to-end space art solutions, dismantling industry pain points through integrated cultural curation and vertical control. Here’s how they reset the logic for artwork customization.

Pain Point 1: Disconnected Art Proposals – The ZhengyinArt Fix

“Generic suppliers recycle existing artwork. We craft living brand narratives.”
Xiao Wei, Art Director, ZhengyinArt

Core Strategy: Artist-Led Co-Creation

  • 30+ In-House Artists embedded from schematic design phase, decoding brand DNA
  • “Space-Culture-Art” Triad Framework: Each art piece becomes a tangible brand icon, transforming interiors into unique art-centric environments

Pain Point 2: Artwork Execution Failures – The ZhengyinArt Fix

On-site installation by the ZhengyinArt team
On-site installation by the ZhengyinArt team

“Broken supply chains sabotage art integrity. We control every micron.”
— Technical Team Lead, ZhengyinArt

Core Strategy: Vertical Art Manufacturing

  • Closed-Loop Ecosystem: Artists + Engineers + Specialized Workshops (copper, ceramics, filigree, glass)
  • Provenance Tracking: Glazes fired at ZhengyinArt’s Jingdezhen Kiln; heritage copper forging via National Masters
  • Artwork Execution Highlights:
    • Singapore Marina Bay Hotel’s ceramic collection, Beijing CITIC Tower’s 40m suspended artwork installation.

Pain Point 3: Collaboration

Projects completed in collaboration with renowned interior design firms
Projects completed in collaboration with renowned interior design firms

Breakdowns – The ZhengyinArt Fix

“Artwork clashes with design intent? We speak Gensler’s language fluently.”
— Global Projects Director, ZhengyinArt

Core Strategy: Design Partnership Protocol

Pain Point 4: Cost Overruns – The ZhengyinArt Fix

“Art shouldn’t bankrupt projects. Our system makes masterpiece artwork financially sustainable.”
— Operations Director, ZhengyinArt

Core Strategy: Value Engineering

  • Eliminate rework via early-stage structural coordination
  • Scale economies through in-house studios (vs. outsourced artist commissions)

The Art-Space Revolution: Beyond Decoration

ZhengyinArt’s art infrastructure proves that curated artwork is a value multiplier:

  • Commercial space deploy sculptural totems amplifying brand recall
  • Luxury hotels leverage site-specific installations boosting ADR

“We engineer artwork experiences, not just objects. Perfect art-space fusion is now a repeatable science.”
Xiao Wei, Art Director, ZhengyinArt

Growth Metric: Transitioning clients from art procurement to cultural operating systems

Explore ZhengyinArt’s Custom Artwork Ecosystem

Catalog for inspiration: www.zhengyinarts.com

Official website: www.zhengyinart.com

Contact: summer@zhengyinart.com 

HOPE Foundation and Taiwan’s Top Lung Cancer Experts Call for Seamless Integration of Early Screening, Precision Diagnostics, and Early Treatment


TAIPEI, TAIWAN – Media OutReach Newswire – 16 August 2025 – Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Yet, progress is within reach. In Taiwan, thanks to the National Lung Cancer Early Detection Program, the proportion of early-stage lung cancer cases continues to rise. Against this backdrop, HOPE Foundation for Cancer Care, one of the largest cancer-focused patient advocacy groups in Taiwan, recently hosted a press conference titled “Healthy Taiwan, Leading the World – Ushering in a New Era of Early Screening and treatment of Lung Cancer”. The event brought together distinguished government officials, ten leading medical authorities in lung cancer, and renowned lung cancer experts from major medical centers nationwide to chart the next phase of early lung cancer prevention and control policies. United in their commitment, participants advocated for the seamless integration of early screening, precision diagnostics, and early treatment in lung cancer care, strengthening efforts to promote early detection and intervention. Ultimately, aiming to support Taiwan in achieving its ambitious goal of reducing cancer mortality rates by one-third by 2030, setting a new international benchmark in cancer control.

IMG_6845.jpeg

Taiwan’s proactive approach to lung cancer prevention is recognized globally for its vision and effectiveness. In July 2022, the government launched the Lung Cancer Early Detection Program, offering biannual low-dose CT (LDCT) screenings for high-risk groups, including those with a family history of lung cancer and heavy smokers. This pioneering initiative has positioned Taiwan as an international role model in lung cancer prevention. Over the past three years, more than 210,000 screenings have led to the identification of 2,506 lung cancer cases—over 80% of which were diagnosed at an early stage, with late-stage diagnoses dropping sevenfold. Previously, late-stage diagnosis was the norm, but Taiwan’s proactive policies have transformed the landscape, reversing the trend and ensuring that most initial lung cancer cases are now detected early.

IMG_6846.jpeg

During his recent visit to Taiwan, Dr. Cary Adams, CEO of the Union for International Cancer Control (UICC), commended Taiwan’s National Cancer Control Program, its comprehensive cancer registry, and robust National Health Insurance (NHI) system for establishing an exemplary cancer care network. He encouraged Taiwan to further improve early lung cancer screening rates and timely access to treatment, reinforcing its status as a global public health leader. At the conference, Minister of Health and Welfare Dr. Chiu Tai-Yuan pledged ongoing cross-ministerial collaboration and policy innovation to improve early lung cancer detection and treatment. Legislator Wang Cheng-Hsu also reaffirmed his commitment to early detection and intervention, advocating for increased resources and improved legislation to ensure early-stage lung cancer patients receive comprehensive care.

Leading medical experts further emphasized Taiwan’s advancements. Dr. Yang, Pan-Chyr, Academician of Academia Sinica, highlighted how the LDCT screening program has driven a shift toward earlier-stage diagnosis, with research indicating it could reduce lung cancer mortality by 53%. Dr. Chen Chien-Jen, Academician of Academia Sinica emphasized that the next key challenge is ensuring early-stage patients benefit from precision diagnostics and early treatment. Dr. Yang Cheng-Ta, President of the Taiwan Lung Cancer Society, added that emerging AI technology is now capable of analyzing LDCT images to predict an individual’s six-year cancer risk, which will improve identification of high-risk groups and support early intervention. Dr. Yang Chih-Hsin, President of Taiwan Association for the Study of Lung Cancer, urged early-stage patients to undergo genetic testing promptly, enabling medical teams to tailor optimal treatment plans, including surgery, targeted therapy, or immunotherapy as adjuvant treatments.

HOPE called for NHI resources to shift toward early lung cancer diagnosis and treatment, highlighting the importance of genetic testing and adjuvant therapy for high-risk early-stage patients to reduce relapse and mortality. Clinical evidence shows that adjuvant targeted therapy after surgery for stage IB–IIIA lung cancer with EGFR mutations can reduce five-year mortality by 10%, which is vital for improving outcomes and easing the burden on the healthcare system. Dr. Chen Jin-Shing, Head of Thoracic Surgery Division at National Taiwan University Hospital, advocated for priority reimbursement of adjuvant targeted therapy for patients with stage IB-IIIA lung cancer, while Dr. Chen Chih-Yi, Board Member of HOPE emphasized the importance of improving access to early genetic testing and treatment. Dr. Huang, Ming-Shyan, President of the Taiwan Clinical Oncology Society, pointed out that early-stage lung cancer treatment in Taiwan is not yet fully aligned with international guidelines, and urged that expanded screening must be matched with optimized NHI resource allocation and improved treatment access.

Other leading voices reinforced the need for comprehensive care. Dr. Wang Chin-Chou, Board Member of Taiwan Society of Pulmonary and Critical Care Medicine, stressed that while surgery is the primary treatment for early-stage lung cancer, it must be accompanied by proactive adjuvant therapy strategies and long-term follow-up. Dr. Chang Wen-Cheng, CEO of Taiwan Cancer Foundation emphasized that the integration of screening, diagnosis, and treatment is crucial to truly realize early detection and treatment, as well as maximizing the value of screening program. Dr. Chen Jen-Shi, President of Taiwan Oncology Society, recommended that in addition to current NHI and Cancer Drug Fund financing, the government should promote diverse payment mechanisms—such as co-payment models or commercial insurance to supplement the NHI system—to further improve access to early lung cancer treatment.

Uniting multiple lung cancer treatment experts from medical centers across Taiwan, a concerted effort to usher in a new era of early lung cancer screening and treatment. (Listed by institution from North to South)
· Dr. Chen Yu-Min, Director of General Chest Medicine Department, Taipei Veterans General Hospital
· Dr. Lee Kang-Yun, Attending Physician, Division of Pulmonary Medicine, Shuang Ho Hospital
· Dr. Huang Chun-Yao, Attending Physician, Division of Chest Medicine, Taipei Tzu Chi Hospital
· Dr. Tsai Chen-Liang, Director of Pulmonary and Critical Care Medicine Division, Tri-Service General Hospital
· Dr. Yeh Yu-Wen, Physician, Division of Thoracic Medicine, Shin Kong Wu Ho-Su Memorial Hospital
· Dr. Chang Sheng-Yu, Attending Physician and Leader of the Lung Cancer Team, Far Eastern Memorial Hospital
· Dr. Yang Tsung-Ying, Director of General Chest Medicine Department, Taichung Veterans General Hospital
· Dr. Hsia Te-Chun, Deputy Director, Department of Internal Medicine, China Medical University Hospital
· Dr. Lin Chien-Chung, Attending Physician, Division of Chest Medicine, National Cheng Kung University Hospital

Hashtag: #HOPEFoundation

The issuer is solely responsible for the content of this announcement.